drugset / Trial / NCT01007552
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
NaSingle-groupOpen-labelTreatment
Summary
To assess the proposed therapy for patients with advanced gallbladder or biliary cancers.
Timeline
- Start
- 2009-12
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | — |
| Subject | Capecitabine | Small molecule | 650 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |